Explore related pages
Related company profiles:
News
Opportunities and Obstacles for Personalized Cancer Vaccines - BioProcess International
Opportunities and Obstacles for Personalized Cancer Vaccines BioProcess International
PharmaLex to merge with Cpharm to enhance presence in Australia - Pharmaceutical Technology
PharmaLex to merge with Cpharm to enhance presence in Australia Pharmaceutical Technology
Behind AmerisourceBergen's PharmaLex buy - Axios
Behind AmerisourceBergen's PharmaLex buy Axios
PharmaLex forms joint venture with consulting firm Vintura - Consultancy.eu
PharmaLex forms joint venture with consulting firm Vintura Consultancy.eu
Growth of Combination Products & Australian Regulatory Updates - BioProcess International
Growth of Combination Products & Australian Regulatory Updates BioProcess International
Supporting Mergers and Acquisitions in the Pharmaceutical/Biopharmaceutical Industry - Global Trade Magazine
Supporting Mergers and Acquisitions in the Pharmaceutical/Biopharmaceutical Industry Global Trade Magazine
3 Q&A Interview with Torben Thers Nørgaard General Manager, Cencora Pharmalex Nordic - mva.org
3 Q&A Interview with Torben Thers Nørgaard General Manager, Cencora Pharmalex Nordic mva.org
PharmaLex announces joint venture with Vintura - PMLiVE
PharmaLex announces joint venture with Vintura PMLiVE
PharmaLex enters merger deal with Ascent Development Services - Pharmaceutical Technology
PharmaLex enters merger deal with Ascent Development Services Pharmaceutical Technology
AmerisourceBergen agrees to acquire PharmaLex for $1.29bn - Pharmaceutical Technology
AmerisourceBergen agrees to acquire PharmaLex for $1.29bn Pharmaceutical Technology
Best-Practice Quality Trends. Going Beyond the Basics in Risk Management - BioProcess International
Best-Practice Quality Trends. Going Beyond the Basics in Risk Management BioProcess International
ATMPs: Chemistry, Manufacturing, and Controls - BioProcess International
ATMPs: Chemistry, Manufacturing, and Controls BioProcess International
From PDFs to Digital Submissions The Rapid Pace of Regulatory Change - BioProcess International
From PDFs to Digital Submissions The Rapid Pace of Regulatory Change BioProcess International
The State of Quality Risk Management in the Pharmaceutical Industry: Commentary on the Draft ICH Q9 Revision - BioProcess International
The State of Quality Risk Management in the Pharmaceutical Industry: Commentary on the Draft ICH Q9 Revision BioProcess International
Centralize, Modernize, Harmonize: The Acceleration of Regulatory Digital Trends - BioProcess International
Centralize, Modernize, Harmonize: The Acceleration of Regulatory Digital Trends BioProcess International
Analytical Method Validation Challenges for Advanced Therapies: Using Gene Therapies as an Example - BioProcess International
Analytical Method Validation Challenges for Advanced Therapies: Using Gene Therapies as an Example BioProcess International
Biopharmaceutical Industry Virtual Audits - BioProcess International
Biopharmaceutical Industry Virtual Audits BioProcess International
Standard Operating Procedures in a Good Practice Environment: Benefit or Burden? - BioProcess International
Standard Operating Procedures in a Good Practice Environment: Benefit or Burden? BioProcess International
Orphan Drug Designation: Securing the Significant Benefits - BioProcess International
Orphan Drug Designation: Securing the Significant Benefits BioProcess International
Preparing for a Virtual Audit - BioProcess International
Preparing for a Virtual Audit BioProcess International
AmerisourceBergen to acquire German biopharma services provider for $1.3B - The Business Journals
AmerisourceBergen to acquire German biopharma services provider for $1.3B The Business Journals
Focus on Aseptic Processing: A Report from the September 2022 PDA Annex 1 Event in Amsterdam - BioProcess International
Focus on Aseptic Processing: A Report from the September 2022 PDA Annex 1 Event in Amsterdam BioProcess International
PharmaLex strengthens global reach and local support with offices in China - BioSpectrum Asia
PharmaLex strengthens global reach and local support with offices in China BioSpectrum Asia
AUCTUS Capital exits PharmaLex to AmerisourceBergen - pehub.com
AUCTUS Capital exits PharmaLex to AmerisourceBergen pehub.com
PharmaLex expands its footprint to Italy - PMLiVE
PharmaLex expands its footprint to Italy PMLiVE
PharmaLex strengthens international team - PMLiVE
PharmaLex strengthens international team PMLiVE
PharmaLex enters Australia following acquisition of ERA Consulting - Consultancy.com.au
PharmaLex enters Australia following acquisition of ERA Consulting Consultancy.com.au
Rules on Ownership of Medicinal Product stock distributed in Great Britain - PharmiWeb.com
Rules on Ownership of Medicinal Product stock distributed in Great Britain PharmiWeb.com
Regulatory divergence presents barriers to EU combined studies - Teknologiateollisuus ry
Regulatory divergence presents barriers to EU combined studies Teknologiateollisuus ry
Piper Alderman assists PharmaLex’s merger with specialist consultancy - Australasian Lawyer
Piper Alderman assists PharmaLex’s merger with specialist consultancy Australasian Lawyer
Companies like Pharmalex - Public Affairs, Communication & Patient Advocacy
Top Pharmalex - Public Affairs, Communication & Patient Advocacy Employees
-
Elisabetta Crippa
Phd In Life And Biomolecular Sciences
Milan, Lombardy, Italy, Italy2gmail.com, ifom-ieo-campus.it -
maria elena mazzucchelli
Art Director Presso Cencora Pharmalex
Milan, Lombardy, Italy, Italy1libero.it -
-
1gmail.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.